Background: The WHO and UNAIDS recommend an integrated strategy for the elimination of congenital syphilis and mother-to-child transmission of HIV. Laboratory-based syphilis diagnostics are complex and implementation can be hampered by logistical difficulties. Recently, test developers have created rapid tests that can detect multiple infections with the same specimen using a single device. The SD BIOLINE HIV/Syphilis Duo qualitative test uses a solid phase immunochromatographic assay to detects antibodies to all isotypes (IgG, IgM, IgA) specific to HIV-1 including subtype-O, HIV-2 and Treponema (T.) pallidum in human serum. This is a simple point-of-care test that can be used in all health care settings to allow immediate treatment. This study was a multisite laboratory-based evaluation of the performance of the SD Bioline HIV/Syphilis Duo test using well- characterized stored serum samples in four countries. Methodology: A total of 4 laboratory sites participated in the evaluation: Ghana, Peru, Togo, Kenya, and Myanmar in 2012 and 2013. Each site used wellcharacterized serum specimens for detection of HIV antibodies and T. pallidum antibodies using the SD Bioline HIV/syphilis duo test, using a combination of Treponema pallidum particle agglutination assay (TPPA) or T.pallidum Hemaglutination Assay (TPHA) and rapid plasma reagin (RPR) for detection of T. pallidum and enzyme immunoassay (EIA), Western Blot, and rapid tests for the detection of HIV antibodies. We calculated the sensitivity and specificity of test performance from the pooled data using the exact binomial method. Results: The test performance from each site is displayed in the table. The pooled sensitivity for the HIV antibody component was estimated to be 99.89% (95% CI: 99.39% to 100%) and the specificity was 99.86% (95% CI: 99.25% to 100%). For the T. pallidum component, the pooled sensitivity was estimated to be 99.80% (95% CI: 98.89% to 99.99%) and the combined specificity was estimated to be 99.71% (95% CI: 99.16% to 99.94%). Conclusions: The sensitivity and specificity of the SD Bioline HIV/Syphilis Duo test using serum were very high at each site for HIV and T. pallidum antibodies when compared to the gold standard testing. This dual test could be a timely breakthrough for the UNAIDS and WHO strategy for the dual elimination of HIV and syphilis. The Bioline HIV/syphilis duo test should be considered for improved coverage of screening for HIV and syphilis infections.